These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neuroleptic malignant syndrome related to use of clozapine. Trayer JS; Fidler DC J Am Osteopath Assoc; 1998 Mar; 98(3):168-9. PubMed ID: 9558834 [TBL] [Abstract][Full Text] [Related]
5. Comment on Neuroleptic malignant syndrome and clozapine monotherapy. Lee JW Aust N Z J Psychiatry; 1997 Jun; 31(3):435-6. PubMed ID: 9226095 [No Abstract] [Full Text] [Related]
6. An apparent neurotoxicity associated with clozapine. Viner MW; Escobar JI J Clin Psychiatry; 1994 Jan; 55(1):38-9. PubMed ID: 8294394 [No Abstract] [Full Text] [Related]
7. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS. Illing M; Ancill R Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793 [No Abstract] [Full Text] [Related]
8. Atropinism may precipitate neuroleptic malignant syndrome during treatment with clozapine. Nemecek D; Rastogi-Cruz D; Csernansky JG Am J Psychiatry; 1993 Oct; 150(10):1561. PubMed ID: 8379567 [No Abstract] [Full Text] [Related]